Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
Athletes looking for better muscle recovery
The STEP trials for semaglutide 2.4 mg (Wegovy) showed: Average weight loss of approximately 15% of body weight over 68 weeks One-third of participants lost 20% or more of body weight Significant reductions in waist circumference, blood pressure, and cardiovascular risk markers The SURMOUNT trials for tirzepatide (Zepbound) showed even more impressive results: Average weight loss of 20-25% at the highest dose (15 mg) over 72 weeks More than half of participants lost 20% or more of body weight Significant improvements in type 2 diabetes markers, blood pressure, and lipid profiles The head-to-head comparison is clear
It's known for being gentle on the digestive system and is less likely to cause gastrointestinal issues than other options
But maybe not for everybody
Around 50% of individuals were female, and 9.2% had type 2 diabetes
US$ 29.14
US$ 24.98
US$ 22.49
US$ 24.32
US$ 22.94
US$ 28.65
US$ 27.23
US$ 23.81
US$ 23.08
US$ 22.29
US$ 20.04
